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ipid rafts are known to aggregate in response to various
stimuli. By way of raft aggregation after stimulation,
signaling molecules in rafts accumulate and interact so
that the signal received at a given membrane receptor is
ampliﬁed efﬁciently from the site of aggregation. To elucidate
the process of lipid raft aggregation during T cell activation,
we analyzed the dynamic changes of a raft-associated
protein, linker for activation of T cells (LAT), on T cell receptor
stimulation using LAT fused to GFP (LAT-GFP). When trans-
fectants expressing LAT-GFP were stimulated with anti-CD3–
coated beads, LAT-GFP aggregated and formed patches
L
 
at the area of bead contact. Photobleaching experiments
using live cells revealed that LAT-GFP in patches was
markedly less mobile than that in nonpatched regions. The
decreased mobility in patches was dependent on raft organ-
ization supported by membrane cholesterol and signaling
molecule binding sites, especially the phospholipase C
 
 
 
1
binding site in the cytoplasmic domain of LAT. Thus, although
LAT normally moves rapidly at the plasma membrane, it
loses its mobility and becomes stably associated with
aggregated rafts to ensure organized and sustained signal
transduction required for T cell activation.
 
Introduction
 
T cell activation commences with the recognition of antigen
by way of the T cell receptor (TCR),* which is expressed on
the surface of T cells. Ligation of the TCR leads to a rapid
rise in intracellular protein tyrosine phosphorylation, followed
by a series of biochemical events that eventually result in
gene expression and effector function (Weiss and Littman,
1994; Wange and Samelson, 1996). Recently, specialized
subdomains of the plasma membrane known as lipid rafts,
consisting of concentrated amounts of sphingolipids and
cholesterol, have been shown to play important roles in early
signal transduction in lymphocytes (Simons and Ikonen,
1997; Cherukuri et al., 2001; van der Goot and Harder,
2001). The existence of lipid rafts on T cell membranes and
their role as platforms for conducting TCR signal transduction
is already well documented (Montixi et al., 1998; Moran
and Miceli, 1998; Xavier et al., 1998; Janes et al., 1999;
Viola et al., 1999; Boerth et al., 2000; Kosugi et al., 2001).
Linker for activation of T cells (LAT) is an adaptor protein
 
that performs a critical function in raft-mediated TCR
signal transduction (Zhang et al., 1998a,b). LAT localizes to
the plasma membrane by way of its transmembrane domain,
and by palmitoylation of two Cys residues in its juxtamembrane
region, it localizes to rafts in the plasma membrane (Zhang
et al., 1998b). In LAT-negative T cell lines, TCR signaling is
severely impaired and cannot be reconstituted by transfection
with LAT mutated at residues required for raft localization,
effectively demonstrating that not only LAT expression, but
also localization of this molecule to rafts is essential for TCR
signaling (Finco et al., 1998; Zhang et al., 1999). After TCR
engagement, LAT is tyrosine-phosphorylated by ZAP-70,
creating docking sites for SH2 domain–containing effector
proteins. Proteins that associate directly or indirectly with
LAT include phospholipase C
 
 
 
1 (PLC
 
 
 
1), phosphoinosi-
tide 3-kinase, Grb2, Gads, Cbl, Vav, Itk, and SLP-76 (Zhang
et al., 1998a, 2000; Shan and Wange, 1999). By binding
with these molecules, LAT activates a series of signaling re-
actions including PLC
 
 
 
1/Ca
 
2
 
 
 
 and Ras/MAPK pathways.
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After TCR stimulation, rafts are thought to aggregate to
mediate binding between raft-localized phosphorylated LAT
and various other signaling molecules. Although rafts on live
cells normally have a diameter of 
 
 
 
70 nm or less (Varma
and Mayor, 1998), after stimulation they aggregate with one
another to become a larger size, and are observable under
light microscopes. By way of raft aggregation after stimula-
tion, signaling molecules in rafts accumulate and interact so
that the signal received at the membrane receptor is ampli-
fied efficiently from the site of aggregation to the inside of
the cell. Thus, raft aggregation is considered to be important
for raft-mediated signaling pathways (Janes et al., 2000; van
der Goot and Harder, 2001). It has already been shown that
raft aggregation after stimulation is observed in T cells (Janes
et al., 1999; Khan et al., 2001). However, the precise role of
raft aggregation in T cell activation is presently unknown. It
may be required for only the initial steps of signaling that in-
duce interaction between LAT and other signaling mole-
cules, leaving the progression of signaling further down-
stream to be predominantly performed by protein–protein
interactions. Alternatively, poststimulatory raft aggregation
may be required until an entire series of initial signals from
the membrane are completed. Additionally, there has also
been little investigation of any real-time kinetic change in
LAT or other raft-localized proteins that may exist in aggre-
gated rafts of individual living cells after TCR stimulation.
In this work, we have created a fusion protein of GFP
connected to the COOH-terminal of LAT to investigate ki-
netic changes in LAT accumulated in aggregated rafts using
fluorescence imaging. Here, we show that LAT present at
sites of raft aggregation after TCR stimulation has mobility
lower than that of LAT found in other areas of the plasma
membrane. Moreover, we found that both raft structure and
signaling molecule binding sites, especially the PLC
 
 
 
1 bind-
ing site in the cytoplasmic domain of LAT, are important
for maintenance of this reduction in LAT mobility in aggre-
gated rafts.
 
Results
 
The LAT-GFP fusion protein localizes to rafts 
and is phosphorylated after TCR stimulation
 
A fusion gene was constructed consisting of GFP linked to
the COOH-terminal of the entire LAT gene coding se-
quence. The LAT-GFP fusion gene was then transfected
into Jurkat cells and stable transfectants were established.
Previously, it has been shown that LAT localizes to rafts by
way of palmitoylation of two Cys residues in its juxtamem-
brane region (Zhang et al., 1998b). To investigate whether
LAT-GFP localized to rafts as per endogenous LAT, LAT-
GFP transfectants were solubilized and the raft fraction was
purified using a sucrose gradient. As shown in Fig. 1 A,
LAT-GFP predominantly exists in rafts like endogenous
LAT, suggesting that the fusion of GFP to LAT does not af-
fect the localization of LAT in the plasma membrane.
Next, we investigated whether the LAT-GFP fusion pro-
tein was functioning as a signaling molecule. After stimula-
tion of LAT-GFP transfectants with OKT3, LAT-GFP was
found to be effectively phosphorylated (Fig. 1 B). We also
observed that phosphorylation of LAT-GFP after TCR
stimulation mainly occurred in the raft fraction (unpub-
lished data). These results strongly suggest that phosphory-
lated LAT-GFP could also function as an adaptor molecule
after TCR engagement in LAT-GFP transfectants.
 
LAT-GFP patches form after T cell contact 
with anti-CD3–coated beads
 
Next, we investigated changes in the localization of LAT-
GFP after TCR stimulation using confocal microscopy.
LAT-GFP transfectants were stimulated with anti-CD3 an-
tibody–coated latex beads, which have previously been re-
ported to act as artificial antigen-presenting cells owing to
their ability to induce cell polarization and reorganization of
the cytoskeleton in Jurkat cells (Lowin-Kropf et al., 1998).
After mixing LAT-GFP transfectants and the beads, these
conjugates were fixed and LAT-GFP fluorescence was ana-
lyzed microscopically. Although LAT-GFP was homoge-
neously distributed at the plasma membrane in unstimu-
lated cells, it became concentrated in distinct patches at the
cell–bead interface in a large proportion of cells stimulated
by the anti-CD3–coated beads (Fig. 2, A and B). When
LAT-GFP transfectants were stimulated with poly-
 
L
 
-lysine–
coated beads as a negative control, no patch formation was
observed at the cell–bead interface.
To determine whether LAT-GFP patch formation was
specifically induced by TCR cross-linking, antibodies di-
rected against a variety of T cell surface molecules were
bound to latex beads and used to stimulate LAT-GFP trans-
fectants. All surface molecules analyzed were expressed at
comparable levels between Jurkat cells and the transfectants
Figure 1. Characterization of the LAT-GFP fusion protein used 
in this work. (A) Localization of LAT-GFP in rafts from LAT-GFP–
transfected Jurkat cells. LAT-GFP transfectants were lysed with MBS 
containing 1% Triton X-100, and the lysates were subjected to 
equilibrium gradient centrifugation. An aliquot of each fraction was 
electrophoresed and immunoblotted with HRP-conjugated CTx-B 
and anti-GFP antibody to detect GM1 and LAT-GFP, respectively. 
Fractions 4 and 5 correspond to the raft fractions. (B) Tyrosine 
phosphorylation of LAT-GFP after TCR cross-linking. The LAT-GFP 
transfectants were stimulated with OKT3 for the times indicated. 
Cell lysates were immunoprecipitated with anti-LAT antibody, and 
immunoprecipitates were analyzed by immunoblotting with anti-PY 
and anti-LAT antibodies. The closed arrowhead indicates LAT-GFP, 
whereas open arrowheads indicate endogenous LAT. The band 
migrating at 55 kD in each lane is the heavy chain (H) of the antibody 
used for immunoprecipitation.T
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(unpublished data). Stimulation with anti-CD28 antibody–
coated beads resulted in a lack of patch formation similar to
that observed for poly-
 
L
 
-lysine beads (Fig. 2, A and B). Little
patch formation was also observed when using beads conju-
gated to antibodies against LFA-1 and CD44 (Fig. 2 B).
These results clearly demonstrate that LAT-GFP patch for-
mation is specifically induced by TCR stimulation.
Next, we analyzed the kinetics of LAT-GFP patch forma-
tion after stimulation with anti-CD3–coated beads. The
number of cell–bead conjugates with LAT-GFP patches in-
creased from 5 min, peaked at 20 min, and continued to be
observed until 90 min from time of initial stimulation. At
20 min after stimulation, anti-CD3–coated beads were
mostly surrounded by the T cell surface and internalized
(Fig. 2 A). Large decreases in the amount of patch formation
were observed from 2 h after stimulation, suggesting that
patch formation continues for 
 
 
 
90 min (Fig. 2 C).
 
Colocalization of raft markers to LAT-GFP patches
 
To determine whether sites of LAT-GFP patch formation
corresponded with sites of raft aggregation, colocalization of
molecules previously reported as raft markers to LAT-GFP
patches was examined. Cholera toxin B (CTx-B) specifically
binds to glycosphingolipids with a strong affinity for gangli-
oside GM1 (GM1), which is enriched in membrane rafts.
Figure 2. TCR-mediated patch formation of LAT-GFP. (A) LAT-GFP 
transfectants were mixed at a 2:1 ratio with poly-L-lysine–, anti-CD28–, 
or anti-CD3–coated latex beads. After 20 min at 37 C, conjugates 
were fixed with formaldehyde and observed by confocal microscopy. 
In the left column are bright-field images, in the middle column are 
LAT-GFP fluorescence images, and the right column contains the 
merged image of left and middle. LAT-GFP patches at the contact 
site between the cell and the bead are indicated by arrows. (B) 
Patch formation of LAT-GFP is specifically induced by TCR/CD3 
cross-linking. LAT-GFP transfectants were mixed for 20 min with 
beads coated with either poly-L-lysine or antibodies against CD3, 
CD28, LFA-1, or CD44. Each column represents the average of at 
least three individual experiments in which more than 100 conju-
gates were scored for patch formation. Cells that incorporated or 
attached to beads were scored as conjugates. Cells that showed at 
least one distinct patch at the bead contact site were scored as 
positive for patch formation. (C) LAT-GFP transfectants were mixed 
with anti-CD3 beads at 37 C for the times indicated. Each column 
represents the average of at least three individual experiments.
Figure 3. Colocalization of raft markers with LAT-GFP at the site 
of patch formation. LAT-GFP transfectants were mixed with anti-CD3 
beads for 20 min. Conjugates were fixed with formaldehyde, 
permeabilized, and stained with biotinylated CTx-B to detect GM1 
or biotinylated anti-Lck, followed by incubation with SA-TR or with 
phalloidin-TRITC to detect F-actin. With regard to the staining for 
CD43, CD45, and CD59, conjugates were stained with biotinylated 
antibodies against CD43, CD45, and CD59 without permeabilization, 
followed by incubation with SA-TR, and were then fixed. Conjugates 
were observed by confocal microscopy. Single confocal sections 
show fluorescence in GFP and Texas red channels.T
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Hence, CTx-B was used to test whether GM1 colocalized
with LAT-GFP patch sites. In addition to GM1, the expres-
sion pattern of CD59, CD45, CD43, Lck, and F-actin was
also investigated. As shown in Fig. 3, GM1 and Lck were
found to clearly colocalize with LAT-GFP patches. In addi-
tion, we observed an accumulation of F-actin in LAT-GFP
patches. Previously, it was reported that raft patches formed
by CD59 and GM1 accumulate F-actin (Harder and Si-
mons, 1999). In contrast, CD43 and CD45, large glycopro-
teins that have been shown to be excluded from rafts (Rod-
gers and Rose, 1996; Janes et al., 1999; Allenspach et al.,
2001), were mostly not colocalized with LAT-GFP patches.
Although CD43 was distributed away from the cell–bead
contact site, CD45 was partially expressed on the plasma
membrane surrounding the beads. CD59, a glycosylphospha-
tidylinositol-anchored protein, could be used as another raft
marker. CD59 formed patches not only at the bead inter-
face, but also at the plasma membrane outside the cell–bead
contact site in response to stimulation with anti-CD3–
coated beads. In most cells, CD59 patches at the bead inter-
face were colocalized with LAT-GFP patches as shown in
Fig. 3, but there existed a certain number of cells that did
not accumulate CD59 at the site of stimulation (unpub-
lished data). Together, these results indicate that LAT-GFP
patches have characteristics specific for aggregated lipid rafts.
 
LAT-GFP in patches is less mobile than that in 
nonpatch regions of the plasma membrane
 
Next, we analyzed the change in mobility of LAT-GFP in
live cells using the FRAP technique. After stimulation of
LAT-GFP transfectants with anti-CD3–coated beads, a sin-
gle photobleach was applied to areas of patch formation and
the fluorescence recovery into these bleached regions was
monitored. As shown in Fig. 4 A, fluorescence in a LAT-
GFP patch was completely lost immediately after pho-
tobleaching, and little recovery was observed even 5 min af-
ter photobleaching. It should be noted that another LAT-
GFP patch just below the bleached area was constantly ob-
served during this experiment. This excludes the possibility
that lack of fluorescence recovery in the bleached region was
due to a movement of the cell, by itself. In contrast to LAT-
GFP in patch areas, fluorescence of LAT-GFP in the plasma
membrane outside the cell–bead interface was quickly recov-
ered (Fig. 4 A). Whether we photobleached patch areas or
the plasma membrane (nonpatch) areas, fluorescence recov-
ered to a plateau level between 1 to 2 min after the initial
bleach. However, although LAT-GFP fluorescence in the
nonpatch area returned to 
 
 
 
70% of total fluorescence, re-
covery in patch areas was limited to only 20% (Fig. 4 B).
The recovery of LAT-GFP fluorescence in the plasma mem-
brane from cells without stimulation was almost equivalent
to that seen for bleaching of the plasma membrane from
cells with bead stimulation (unpublished data). These results
suggest that LAT localized in areas of raft aggregation has a
remarkably low mobility compared with that in the plasma
membrane outside aggregated rafts. LAT that does not accu-
mulate in aggregated rafts maintains its rapid mobility irre-
spective of TCR stimulation.
 
The mobility of LAT-GFP in patches 
in primary activated T cells
 
Because dynamics of LAT after T cell activation could be
different in primary T cells compared with that in Jurkat
cells, we next investigated the mobility of LAT-GFP in pri-
mary activated T cells. C57BL/6 T cells were activated with
anti-CD3 plus anti-CD28 and transduced with retrovirus
encoding LAT-GFP. These cells were stimulated with anti-
body-coated beads and LAT-GFP fluorescence was ana-
lyzed. Because a previous report demonstrated that raft ag-
gregation was greatly influenced by costimulatory signal in
primary resting T cells (Viola et al., 1999), we compared the
efficiency of patch formation in cells stimulated with beads
coated with anti-TCR alone or with anti-TCR plus anti-
CD28. As shown in Fig. 5 (A and B), LAT-GFP patches
similar to that observed in Jurkat-derived transfectants were
clearly detectable when cells were stimulated with anti-TCR
plus anti-CD28 beads. Although stimulation for primary T
cells with anti-TCR beads alone was able to induce LAT-
Figure 4. LAT-GFP localized in patches is less 
mobile than that in nonpatched regions of the 
plasma membrane. (A) After LAT-GFP transfectants 
were mixed with anti-CD3 beads for 20 min, a 
selected area (2- m square) on the LAT-GFP 
patches or LAT-GFP in the plasma membrane (PM) 
was photobleached, and fluorescence recovery 
was monitored. Images at representative time points 
are shown. (B) Bleaching recovery kinetics is 
represented as the percentage of FRAP for LAT-GFP 
in patches and that in the plasma membrane. Data 
are representative of five individual experiments.T
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GFP patches qualitatively similar to those observed in anti-
TCR plus anti-CD28 bead stimulation, the frequency of
patch formation was clearly reduced (Fig. 5 B). This suggests
that the requirements for activation of raft aggregation are
different in Jurkat and primary activated T cells.
The results obtained by FRAP experiments using live pri-
mary T cells were almost identical to those in Jurkat-derived
transfectants. Although the recovery of LAT-GFP fluores-
cence in the nonpatch area of the plasma membrane reached
50%, that in patch areas was 
 
 
 
20% (Fig. 5, C and D). This
result strongly argues that LAT mobility is generally reduced
in the aggregated rafts of activated T cells.
 
Effects of cholesterol depletion on the mobility 
of LAT-GFP
 
Next, we wanted to determine the effect of cholesterol de-
pletion on the mobility of LAT-GFP after TCR stimulation.
To this end, we used methyl-
 
 
 
-cyclodextrin (M
 
 
 
CD), a re-
agent that selectively binds and removes cholesterol from the
plasma membrane (Klein et al., 1995). Because extraction
with 10 mM M
 
 
 
CD for longer than 20 min resulted in sig-
nificant cell death due to the strong toxicity (unpublished
data), we reduced the concentration of M
 
 
 
CD to 4 mM. It
was reported that Jurkat cells can be viably cultured for 40
min or more while reducing cholesterol levels to 
 
 
 
50% with
this concentration (Harder and Kuhn, 2000), and we con-
firmed a similar reduction in cholesterol by lipid analysis us-
ing high performance thin layer chromatography (HPTLC;
Fig. 6 A). When we analyzed tyrosine phosphorylation of in-
tracellular proteins after TCR stimulation in Jurkat cells
treated for 40 min with 4 mM M
 
 
 
CD, we found no signifi-
cant inhibition in this response (Fig. 6 B). Tyrosine phos-
phorylation of intracellular proteins and an increase of intra-
cellular Ca
 
2
 
 
 
 (unpublished data) were both clearly induced
in response to TCR stimulation in Jurkat cells extracted un-
der this condition, suggesting that extraction with 4 mM
M
 
 
 
CD for 40 min does not affect early signaling events af-
ter TCR stimulation. However, we observed a clear inhibi-
tion of late signaling events with this treatment. Because
prolonged treatments with M
 
 
 
CD significantly reduced cell
viability even at a concentration of 4 mM, we analyzed the
induction of NFAT transcriptional factor in M
 
 
 
CD-treated
cells with the following protocol: Jurkat cells were tran-
siently transfected with an NFAT-luc reporter plasmid;
treated with M
 
 
 
CD for 40 min; washed; stimulated with
OKT3 or PMA plus ionomycin in conditioned culture me-
dium without FCS for 6 h; and tested for NFAT activity. In
this assay, we observed a significant reduction in TCR-medi-
ated NFAT activation by M
 
 
 
CD treatment without detri-
ment to cell viability and recovery (Fig. 6 C). Culturing
M
 
 
 
CD-treated Jurkat cells in medium containing 10% FCS
completely cancelled the inhibition NFAT activity, presum-
ably due to incorporation of exogenous cholesterol in FCS
into cells (unpublished data). Together, extraction with 4
mM M
 
 
 
CD for 40 min seemed to impair late signaling
events without affecting early signaling events after TCR
stimulation.
After culturing LAT-GFP transfectants for 40 min in 4
mM M
 
 
 
CD, the cells were stimulated with anti-CD3–
coated beads in the presence of 4 mM M
 
 
 
CD for 20 min.
The effect of this treatment was then observed by confocal
microscopy. LAT-GFP patches were clearly observed at the
interface between cells and beads, and there was no signifi-
Figure 5. The mobility of LAT-GFP in patches in primary activated 
T cells. Primary activated T cells transduced with LAT-GFP were 
stimulated with antibody-coated beads and LAT-GFP fluorescence 
was analyzed. (A and B) Primary activated T cells were stimulated 
with poly-L-lysine–, anti-CD28 (PV1)–, anti-TCR  (H57)–, or anti-
TCR  plus anti-CD28 (H57 PV-1)–coated beads. After 20 min at 
37 C, conjugates were fixed with formaldehyde and observed by 
confocal microscopy. In the left column are differential interference 
contrast (DIC) images, and in the left column are LAT-GFP fluores-
cence images. Each column represents the average of at least three 
individual experiments in which more than 100 conjugates were 
scored for patch formation. (C) A selected area (2- m square) on the 
LAT-GFP patches or LAT-GFP in the plasma membrane (PM) was 
photobleached, and fluorescence recovery was monitored. Images 
at representative time points are shown. (D) Bleaching recovery 
kinetics is represented as the percentage of FRAP for LAT-GFP in 
patches and that in the plasma membrane. Data are representative 
of three individual experiments.T
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cant difference in the frequency of patch formation be-
tween M
 
 
 
CD-treated cells and cells without treatment
(Fig. 6 D). This result indicates that successful activation
of early signaling pathways in M
 
 
 
CD-treated cells appears
to be sufficient to induce LAT-GFP patch formation.
However, when FRAP was performed to assess the mobil-
ity of LAT-GFP under M
 
 
 
CD treatment, we observed a
striking effect for cholesterol depletion. As shown in Fig. 6
E, LAT-GFP localized in patches from M
 
 
 
CD-treated
cells recovered very quickly after photobleaching, whereas
that from nontreated cells demonstrated a limited recovery
as before (Fig. 4 A). For both M
 
 
 
CD-treated and non-
treated cells, LAT-GFP fluorescence returned to maximal
levels within 1 min. However, whereas the recovery was
only 20% in nontreated cells, this percentage increased to
50% in M
 
 
 
CD-treated cells (Fig. 6 F). Thus, M
 
 
 
CD
treatment clearly induced an increase in the mobility of
molecules in LAT-GFP patches. These results suggest that
when cholesterol is removed from the cell, raft structure is
altered, resulting in the inability of LAT that usually aggre-
gates and resides in aggregated rafts to remain in the same
position. The correlation between the increased mobility
of LAT-GFP and the inhibition of NFAT activity (Fig. 6
C) indicates the importance of LAT mobility in aggregated
rafts for T cell activation.
 
The role of the cytoplasmic domain of LAT 
in the mobility of LAT in aggregated rafts
 
The cytoplasmic domain of LAT has previously been re-
ported to be essential for the interaction of LAT with other
signaling molecules (Zhang et al., 2000). To investigate
whether LAT-GFP patch formation after TCR stimulation
is dependent on the cytoplasmic domain of LAT, and hence,
interactions between LAT and other signaling molecules,
Jurkat-derived transfectants expressing a fusion protein con-
sisting of the 36 amino acid NH
 
2
 
-terminal transmembrane
domain of LAT fused to GFP, LAT(TM)-GFP, were estab-
lished. Although this fusion protein contains the two Cys
residues required for LAT palmitoylation, it does not con-
tain multiple tyrosine residues that are indispensable for in-
teraction with other proteins. After stimulation by anti-
CD3–coated beads, LAT(TM)-GFP transfectants were
observed by confocal microscopy and scored for patch for-
mation. The extent of patch formation at the cell–bead in-
terface in LAT(TM)-GFP transfectants was comparable to
that in LAT-GFP transfectants (Fig. 7, A and B). Moreover,
the size of patches was similar in both LAT- and LAT(TM)-
GFP transfectants. Thus, these results clearly demonstrate
that the presence of transmembrane domain of LAT is suffi-
cient for accumulation of LAT into aggregated rafts in re-
sponse to TCR stimulation.
Next, we investigated whether the cytoplasmic domain of
LAT is required for the reduction in LAT mobility seen after
TCR stimulation. LAT(TM)-GFP transfectants were stimu-
lated with anti-CD3–coated beads, and photobleaching was
performed on regions of patch formation. Compared with
LAT-GFP, the recovery after bleaching was considerably
greater in LAT(TM)-GFP transfectants (Fig. 7 C). The fluo-
rescence recovery was reached 40% of total fluorescence 1
min after bleaching, and remained at this percentage during
a 5-min time course (Fig. 7 D). Thus, the cytoplasmic do-
main of LAT is important for the reduction in the mobility
of LAT at areas of patch formation.
Figure 6. The effect of cholesterol depletion on the mobility of 
LAT-GFP in patches. (A) Cholesterol in Jurkat cells treated with or 
without 4 mM M CD for 40 min was extracted, separated with 
HPTLC, and visualized with 3% cupric acetate/8% phosphoric acid. 
(B) Jurkat cells treated with or without M CD were stimulated with 
OKT3 for the times indicated. Tyrosine phosphorylation of cellular 
proteins was analyzed by immunoblotting using anti-PY antibody. 
(C) Jurkat cells were transiently transfected with an NFAT-luc 
reporter plasmid, treated with M CD for 40 min, washed, stimulated 
with OKT3 or PMA plus ionomycin (P I) in conditioned culture 
medium without FCS for 6 h, and then tested for NFAT activity by 
NFAT reporter assay. (D) After LAT-GFP transfectants were pretreated 
for 40 min with 4 mM M CD, the cells were stimulated with poly-
L-lysine beads or anti-CD3 beads for 20 min in the presence of 4 mM 
M CD. Conjugates were fixed with formaldehyde and observed by 
confocal microscopy. (E) A selected area (2- m square) on the 
LAT-GFP patches in LAT-GFP transfectants treated with or without 
M CD was photobleached, and fluorescence recovery was monitored. 
(F) Bleaching recovery kinetics is represented as the percentage of 
FRAP for LAT-GFP in patches in the presence or absence of M CD. 
Data are representative of three individual experiments.T
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The PLC
 
 
 
1 binding site in LAT is important for the 
reduced mobility of LAT in aggregated rafts
 
After TCR engagement, LAT is tyrosine-phosphorylated by
ZAP-70, creating docking sites for multiple downstream ef-
fector proteins. It has been shown that the distal four tyro-
sine residues of LAT bind PLC
 
 
 
1, Grb2, and Gads, and
these interactions are essential for TCR signal transduction
(Zhang et al., 2000; Sommers et al., 2001). Next, we wanted
to determine which molecular interactions influence LAT
mobility in aggregated rafts. We established the following
Jurkat-derived transfectants expressing different LAT-GFP
mutants containing substitutions of critical tyrosines with
phenylalanines in the LAT cytoplasmic domain (Fig. 8 A):
LAT(Y136F)-GFP with a mutation at Tyr
 
136
 
, a site for
PLC
 
 
 
1 binding; LAT(3YF)-GFP with mutations at Tyr
 
175
 
,
Tyr
 
195
 
, and Tyr
 
235
 
, sites for Grb2/Gads binding; and
LAT(4YF)-GFP with mutations at the above four tyrosine
residues that abolish both PLC
 
 
 
1- and Grb2/Gads-binding.
To confirm the association of LAT-GFP with PLC
 
 
 
1 or
Grb2, we activated the transfectants with OKT3, immuno-
precipitated PLC
 
 
 
1, or Grb2 with specific antibodies, and
detected LAT-GFP association by anti-GFP blotting (Fig. 8
B). Although PLC
 
 
 
1 and Grb2 were clearly associated with
LAT-GFP in the wild-type LAT-GFP transfectant, muta-
tions of the distal four tyrosines in the LAT(4YF)-GFP
transfectant completely abolished these interactions. As ex-
pected, a mutation at Tyr
 
136
 
 abrogated PLC
 
 
 
1 binding with
LAT, but not Grb2 binding. In the LAT(3YF)-GFP mu-
tant, the association of Grb2 with LAT was almost absent,
and that of PLC
 
 
 
1 with LAT was also undetectable (un-
published data). This is consistent with previous findings
(Zhang et al., 2000), and we did not further analyze the
LAT(3YF)-GFP transfectant because it was impossible to
distinguish LAT(3YF)-GFP from LAT(4YF)-GFP in terms
of protein interactions.
Using the above LAT-GFP mutants, we performed FRAP
experiments to assess effects of protein interactions on LAT
mobility. The extent of patch formation in response to anti-
CD3–coated bead stimulation was comparable between
LAT-GFP, LAT(Y136F)-GFP, and LAT(4YF)-GFP trans-
fectants (unpublished data). In contrast to the low recovery
of LAT-GFP fluorescence after photobleaching in LAT-
GFP transfectants, the recovery of LAT(4YF)-GFP was con-
siderably higher. Moreover, improved fluorescence recovery
was also observed in LAT(Y136F)-GFP transfectants (Fig. 8,
C and D). These results indicate that LAT localizes to aggre-
gated rafts in a stable manner by way of protein interactions;
especially PLC
 
 
 
1 binding.
Discussion
Analysis using live LAT-GFP transfectants revealed that
LAT-GFP is homogeneously distributed throughout the
plasma membrane (Figs. 4–8). Patches were rarely visible at
the plasma membrane, suggesting that in lymphocytes, rafts
do not exist in large size. However, when these cells were
stimulated with anti-CD3–coated beads, rafts aggregated
and patches were formed around the circumference of the
beads. This patch formation was specifically dependent on
TCR stimulation, and could not be induced by stimulation
with beads conjugated to anti-CD28 antibodies or antibod-
ies against adhesion molecules. Consistent with our results,
it has been reported that when Jurkat cells are stimulated
with anti-CD3–coated beads, LAT accumulates at the bead–
cell contact area, and microtubule-organizing center reorien-
tation and actin polymerization are observed toward the
bead attachment site (Lowin-Kropf et al., 1998; Harder and
Kuhn, 2000). In contrast, Viola et al. (1999) have reported
that although formation of a dense cap (raft capping) can be
induced in the zone of contact when human resting T cells
are stimulated with beads coated with both anti-CD3 and
Figure 7. The mobility of LAT(TM)-GFP in patches after TCR 
stimulation. Jurkat-derived transfectants expressing LAT-GFP or 
LAT(TM)-GFP were mixed with anti-CD3 beads for 20 min. (A) Con-
jugates were fixed with formaldehyde and observed by confocal 
microscopy. In the left column are differential interference contrast 
(DIC) images, and in the left column are LAT-GFP fluorescence 
images. LAT-GFP and LAT(TM)-GFP patches were observed at the 
contact site between the cell and the bead. (B) Each column represents 
the average of at least three individual experiments in which more 
than 100 conjugates were scored for patch formation. (C) A selected 
area (2- m square) on the LAT/GFP or LAT(TM)-GFP patches was 
photobleached, and fluorescence recovery was monitored. Images 
at representative time points are shown. (D) Bleaching recovery 
kinetics is represented as the percentage of FRAP for LAT-GFP and 
LAT(TM)-GFP in patches. Data are representative of five individual 
experiments.T
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anti-CD28 antibodies, stimulation for these cells with anti-
CD3–coated beads alone is not able to induce raft aggrega-
tion. Thus, it is conceivable that depending on the cell type
used, there are different requirements for raft aggregation
and cytoskeletal changes. Indeed, we observed that the ef-
ficiency of LAT-GFP patch formation was different in
mouse-activated T cells stimulated with anti-TCR–coated
beads or beads coated with anti-TCR plus anti-CD28 (Fig.
5 B). In contrast to the data using resting T cells reported
earlier (Viola et al., 1999), we were not able to detect raft
capping in primary activated T cells stimulated with anti-
TCR– and anti-CD28–coated beads.
Although molecules involved in raft aggregation have
been reported (Krawczyk et al., 2000), the mechanism for
activation-dependent raft aggregation remains obscure.
However, several possibilities can be envisioned for this.
First, although raft-associated receptors could be separated
in different small rafts before activation, receptor oligomer-
ization could be induced by ligand-mediated cross-linking,
which results in coalescence of small rafts into a larger do-
main. Cross-linking of the Fc  receptor with IgE plus anti-
gen has been shown to trigger aggregation of DiI, a fluores-
cent probe thought to partition into rafts (Thomas et al.,
1994). A second mechanism by which raft aggregation could
be promoted is by increasing affinity for rafts of a protein
that does not reside in rafts before stimulation. After an acti-
vation-dependent change in its affinity, the protein accumu-
lates in rafts and induces coalescence of small raft domains
by way of interaction with other raft-associated proteins.
Lipid modification such as palmitoylation is one mechanism
that can increase the affinity of a given protein to rafts. Fi-
nally, a specific molecule such as agrin, an extracellular pro-
teoglycan, could be primarily responsible for raft aggregation
(Khan et al., 2001). The activated, deglycosylated form of
agrin can be produced by activated T cells and has been
shown to drive raft clustering presumably due to its lectin-
like capacity. The molecular mechanisms by which the sig-
nal from the TCR induces raft aggregation are still un-
known. Because the above mechanisms are not mutually
exclusive, combined machinery may be operative to induce
raft aggregation in T cells.
The data derived using the photobleaching techniques
clearly demonstrated that LAT associated with aggregated
rafts becomes less mobile and does not exchange with LAT in
the plasma membrane outside aggregated rafts. This result
can be explained by several possibilities. In response to raft
aggregation, raft-associated lipids and proteins might be
strongly packed in the plasma membrane, which leads to the
inhibition of their mobility. Moreover, because a variety of
signal transduction molecules are known to be recruited to
rafts after TCR stimulation, protein–protein or protein–lipid
interactions that are actively promoted in aggregated rafts
may also act as an impediment to the mobility of raft-local-
ized molecules. Indeed, the mobility of LAT(TM)-GFP and
LAT(4YF)-GFP in patches was considerably higher com-
pared with that of LAT-GFP (Figs. 7 and 8). This suggests
that protein–protein interactions mediated through the cyto-
plasmic domain of LAT have a great influence on LAT mo-
bility. Consistent with our observation, Harder and Kuhn
have demonstrated that LAT/TCR assemblies are important
Figure 8. The PLC 1 binding site of LAT is important for the 
reduced mobility of LAT in aggregated rafts. (A) Schematic 
representations of the LAT-GFP, LAT(Y136F)-GFP, and LAT(4YF)-
GFP fusion proteins. A LAT-GFP chimera was constructed by 
attaching EGFP to the full length of mouse LAT. Y136 is a binding 
site for PLC 1, and Y175, Y195, and Y235 are binding sites for 
Grb2/Gads in mouse LAT. Mutated amino acids are shown for each 
construct. (B) Association of LAT-GFP with PLC 1 or Grb2. The 
LAT-GFP, LAT(Y136F)-GFP, and LAT(4YF)-GFP transfectants were 
stimulated with OKT3 for 5 min. Cell lysates were immunoprecipitated 
with either anti-PLC 1 or anti-Grb2 antibody, and immunoprecipi-
tates were analyzed by immunoblotting with anti-GFP and antibodies 
specific for the immunoprecipitated protein. (C) After the LAT-GFP, 
LAT(Y136F)-GFP, and LAT(4YF)-GFP transfectants were mixed with 
anti-CD3 beads for 20 min, a selected area (2- m square) on the 
patches was photobleached, and fluorescence recovery was moni-
tored. Images at representative time points are shown. (D) Bleaching 
recovery kinetics is represented as the percentage of FRAP in 
patches. Data are representative of three individual experiments.T
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to form a structural scaffold for TCR signal transduction pro-
teins using a novel method to immunoisolate plasma mem-
brane subfragments (Harder and Kuhn, 2000). With regard
to associated proteins that mainly affect LAT mobility, we
demonstrated that the PLC 1 binding site in LAT is critical
for LAT dynamics in membrane rafts after TCR stimulation
(Fig. 8, C and D). The mechanism for a specific role of
PLC 1 over other associated proteins in LAT mobility re-
mains to be determined, but the existence of an NH2-termi-
nal pleckstrin homology domain in PLC 1, which is known
to contribute the association of PLC 1 with the plasma
membrane, could affect LAT mobility in aggregated rafts.
In addition to protein–protein interactions, raft struc-
ture supported by membrane cholesterol appears to be im-
portant for maintaining LAT mobility in aggregated rafts.
Because extraction with 10 mM M CD impairs Jurkat
cells irreversibly, we treated Jurkat cells and LAT-GFP
transfectants with 4 mM M CD for 40 min to induce
cholesterol depletion. It was reported that signaling pro-
teins accumulated in TCR-enriched immunoisolates and
the amounts of LAT and Lck in the raft fractions were
both clearly reduced in cells treated with the same concen-
tration of M CD (Harder and Kuhn, 2000). Furthermore,
they demonstrated that signal transduction such as tyrosine
phosphorylation of cellular proteins was inhibited with this
treatment. In contrast to their data, we could not observe
an inhibition of tyrosine phosphorylation of cellular pro-
teins (Fig. 6 B) or of Ca
2  response (unpublished data) by
this treatment. Successful activation of early signaling
events under this M CD treatment may lead to efficient
patch formation of LAT-GFP (Fig. 6 D). Therefore, it is
possible that the initial process of raft aggregation on stim-
ulation is relatively resistant to cholesterol depletion. How-
ever, raft structure at the area of raft aggregation has been
changed by this treatment because it was found that the
mobility of LAT-GFP in patches markedly increased (Fig.
6, E and F). Intriguingly, in association with the increased
mobility of LAT-GFP, NFAT transcriptional activity was
significantly impaired in cells treated with 4 mM M CD
(Fig. 6 C). Thus, disruption of raft structure may impair
the stability of raft-associated proteins in aggregated rafts,
resulting in the inhibition of protein–protein interactions
necessary for TCR-mediated signal transduction. Because
initial signaling events were not impaired, we believe that
the increased mobility of LAT-GFP is not a secondary con-
sequence of the inhibition of protein–protein interactions
for TCR signaling by M CD treatment, but is directly re-
lated to the changes of raft structure. The results also imply
that raft organization and the decreased mobility of LAT in
aggregated rafts should be maintained during the progres-
sion of signaling events at the plasma membrane.
Another factor that affects the mobility of raft-localized
proteins could be cytoskeletal reorganization associated with
raft clustering (Bunnell et al., 2001; Miceli et al., 2001). It
has already been shown that raft patches formed by cross-
linking of glycosylphosphatidylinositol-anchored proteins
and GM1 accumulate F-actin in Jurkat cells (Harder and
Simons, 1999). We have also observed in this work that
F-actin was colocalized with LAT-GFP patches (Fig. 3). It is
not surprising that molecules in aggregated rafts with cyto-
skeletally associated structures could be restricted in their mo-
bility compared with those in other areas of the plasma mem-
brane. Whatever the mechanism by which LAT mobility is
decreased after raft aggregation, further experiments using
raft-associated proteins other than LAT appear to be neces-
sary to confirm whether our findings elucidate a generalized
feature for proteins in aggregated rafts. Moreover, although
we have focused on raft-localized proteins in this study, it is
also important to investigate whether lipids that constitute
rafts exhibit the same characteristics as these proteins.
In this analysis, we used a raft-localized protein (LAT) to
provide the first report of the dynamics of rafts in live T
cells. We believe the assay system described in this report
will be highly useful for the analysis of molecular interac-
tions in rafts on T cells in the future. We also anticipate
that highly evolved systems, such as spatio-temporal inves-
tigation using FRET-based sensors, will supply an even
more detailed view of the change in mobility of molecules
accumulated in rafts and the molecular interactions be-
tween different molecules in aggregated rafts during T cell
activation.
Materials and methods
DNA construction
A DNA fragment coding for the full-length murine LAT (Zhang et al.,
1998a) was obtained by RT-PCR using the 2B4 T cell hybridoma cDNA
(Samelson et al., 1983) as a template. The sense and the antisense primers
contained restriction sites for XhoI and for BamHI, respectively. The frag-
ment was subcloned into pPCR-Script
® (Stratagene) and was sequenced. A
DNA fragment coding for EGFP was obtained from pEGFP-N1 vector
(CLONTECH Laboratories, Inc.). The XhoI/BamHI fragment from pPCR-
Script
® containing full-length LAT and the BamHI/NotI fragment from
pEGFP-N1 were then subcloned into the XhoI/NotI site of pMKIT Neo, an
SR  promoter–driven expression vector (provided by Dr. K. Maruyama,
Tokyo Medical and Dental University, Tokyo, Japan), and sequenced to
check the junctional sequence. The predicted molecular mass of the LAT-
GFP fusion protein is  65 kD. A LAT(TM)-GFP chimera was constructed
by replacing the full-length LAT with the 36 NH2-terminal amino acids in
LAT. The LAT(Y136F)-GFP and LAT(4YF)-GFP mutants were generated
from the wild-type LAT-GFP cDNA in pMKIT Neo vector using the Strat-
agene QuikChange
® kit.
Cell culture and transfection
Jurkat cells were cultured in RPMI 1640 medium supplemented with 10%
FCS, 50  M 2-mercaptoethanol, 2 mM L-glutamine, and antibiotics. Jurkat-
derived stable transfectants were established as described previously (Sai-
toh et al., 1995). Growing colonies after transfection were expanded in se-
lective media supplemented with G418 (GIBCO BRL) at 1 mg/ml and as-
sayed for LAT-GFP expression by fluorescence microscopy. Clones that
express LAT-GFP at a high level, as analyzed by flow cytometry, were se-
lected for further study. We also confirmed a similar level of TCR expres-
sion in our LAT-GFP transfectants as compared with Jurkat cells.
Retroviral-mediated gene transfer
LAT-GFP was cloned into the pMX-puro retroviral vector (Onishi et al.,
1998). Plat-E cells (6   10
5 cells per well), the potent retrovirus-packaging
cell line derived from 293T cells (Morita et al., 2000), were plated into a
6-well plate, incubated for 24 h, and then transfected with 1  g of the
pMX-puro–harboring LAT-GFP in conjunction with 3  l FuGENE™ (Roche
Diagnostics) according to the manufacturer’s recommendation. 24 h after
transfection, the culture medium was replaced with fresh medium (10%
FCS/RPMI 1640), the cells were continued to be cultured for another 24 h,
and the virus-containing medium was collected and filtered. Purified
C57BL/6 T cells were activated with 2C11 and PV-1 and were infected af-
ter 36 h using a 1:2 volume of viral supernatant and polybrene (Sigma-
Aldrich) at 4  g /ml, centrifuged at 2,500 rpm for 90 min at 30 C, and in-
cubated at 37 C for 6 h before being supplied with fresh media with IL-2
(37.5 U/ml) and expanded until day 5 after primary activation.T
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Antibodies and reagents
The following antibodies were used: OKT3 (American Type Culture Col-
lection), anti-CD3  mAb; CLB-402 (CALTAG Laboratories), anti-CD28
mAb; MEM-25 (CALTAG Laboratories), anti-LFA-1 mAb; IM7.8.1 (CEDAR-
LANE Laboratories Limited), anti-CD44 mAb; anti-LAT pAb (Upstate Bio-
technology); BRA-10G (Cymbus Biotechnology Ltd.), biotin-conjugated
anti-CD59 antibody; BHPT-1 (Exalpha Biologicals), biotin-conjugated anti-
CD45 antibody; DFT-1 (Cosmo Bio Co.) biotin-conjugated anti-CD43
mAb; MOL171 (Kosugi et al., 2001), biotin-conjugated anti-Lck mAb;
PY20 (Transduction Laboratories), anti-phosphotyrosine mAb; anti-PLC 1
mAb (Upstate Biotechnology); sc-255 (Santa Cruz Biotechnology, Inc.),
anti-Grb2 pAb; and anti-GFP pAb (Medical & Biological Laboratories Co.,
Ltd.). The antibodies against mouse surface antigens were as follows: 2C11
(BD Biosciences), anti-CD3  mAb; H57–597 (BD Biosciences), anti-TCR 
mAb; and PV-1 (Southern Biotechnology Associates, Inc.), anti-CD28
mAb. M CD, poly-L-lysine, phalloidin-TRITC, and biotin-conjugated CTx-B
were purchased from Sigma-Aldrich. Polystylene latex microspheres and
streptavidin-Texas red (SA-TR) were purchased from Polysciences, Inc. and
Molecular Probes, Inc., respectively.
Stimulation of cells with antibody-coated beads 
and confocal microscopy
Antibodies were absorbed to 6- m-diam latex beads as described previ-
ously (Lowin-Kropf et al., 1998). In brief, 10  g of purified antibody were
mixed with 10
7 polystyrene beads in a final volume of 1 ml PBS, and incu-
bated for 90 min at RT with constant tumbling. Beads were then blocked in
1.5 ml PBS/1% BSA for 30 min. After three washes in PBS, latex beads were
resuspended in PBS and stored at 4 C. Efficient antibody absorption was
verified by flow cytometry. LAT-GFP transfectants (2   10
5) were mixed
with antibody-coated beads (10
5) for 20 min at 37 C. We stimulated cells
for 20 min unless otherwise specified (Fig. 2 C). The cell–bead mixture was
then fixed for 10 min in PBS/3.7% formaldehyde, and samples were
mounted on slides and viewed under a confocal microscope. In some ex-
periments, cells were incubated with either 1–10  g/ml biotin-conjugated
antibodies or 5  g/ml biotin-conjugated CTx-B, followed by 10  g/ml SA-
TR. LAT-GFP patch formation was scored as positive if at least one distinct
patch was observed at the bead contact area. We counted more than 100
cells that incorporated or were in contact with beads, and calculated the
percentage of the patch formation. Confocal microscopy was performed
with a 63 /1.4 oil objective lens on a confocal microscope (model LSM
510; Carl Zeiss MicroImaging, Inc.), using laser excitation at 488 and 543
nm. The widths of GFP and Texas red emission channels were set such that
bleed-through across channels was negligible.
FRAP experiments
After LAT-GFP transfectants were mixed with anti-CD3 beads, conjugates
were placed on slides in culture medium (10% FCS/RPMI 1640 without phe-
nol red and 25 mM Hepes) that was prewarmed at 37 C without fixation. A
selected area (2- m square) on the LAT/GFP patches was photobleached for
3–5 s by 488 nm laser at 18 mW. Pre- and postbleach images were collected
periodically until fluorescence was recovered at a plateau level, and the
fluorescence intensity in the photobleached area of each image was mea-
sured. The postbleach intensity was corrected for overall loss of fluorescence
determined from total fluorescence in the whole-cell images taken at the
beginning and end of the experiment. Bleaching recovery kinetics is re-
presented as the percentage of FRAP (Spector et al., 1997). The corrected
pre- and postbleach intensities are normalized to 100 and 0%, respectively.
During FRAP experiments described above, we did not strictly control the
temperature of medium in which cell–bead conjugates were suspended us-
ing a heated stage. However, we did not observe any difference between the
results of FRAP experiments with or without using a heated stage.
M CD treatment
Jurkat cells were pretreated with 4 mM M CD for 40 min at 37 C. After
washing, the cells were stimulated with OKT3, and tyrosine phosphoryla-
tion of cellular proteins was analyzed as described previously (Kosugi et
al., 2001). For NFAT-luc reporter assays, Jurkat cells (5   10
5) were trans-
fected with 500 ng of NFAT-luc and 50 ng of pRL-TK using DMRIE-C
(GIBCO BRL). One day after transfection, cells were treated with 4 mM
M CD for 40 min, washed, and then stimulated with 1  g/ml immobilized
OKT3, or 1  M ionomycin plus 50 ng/ml PMA for 6 h in conditioned me-
dium that did not contain FCS. As conditioned medium, we used RPMI
1640 with twofold Insulin-Transferrin-Selenium-S Supplement (GIBCO
BRL). For LAT-GFP patch formation and FRAP experiments, LAT-GFP
transfectants were pretreated with 4 mM M CD for 40 min at 37 C, and
stimulated with anti-CD3–coated beads in the presence of M CD.
Lipid analysis
Cells (10
7) were collected, washed twice with PBS, and the lipids were ex-
tracted from the cell pellets as described previously (Inokuchi et al., 2000).
Lipids were separated by HPTLC and were visualized with 3% cupric ace-
tate/8% phosphoric acid.
Isolation of a raft fraction, immunoprecipitation, and 
immunoblotting analysis
Isolation of a raft fraction, immunoprecipitation, and immunoblotting anal-
ysis were performed as described previously (Kosugi et al., 2001).
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